Topical Treatments for Psoriasis for Patients With Skin of Color

This is a video synopsis/summary of a panel discussion involving Linda Stein Gold, MD; Mona Shahriari, MD, FAAD; and Seemal Desai, MD.

In discussing the treatment of psoriasis in patients with skin of color, the conversation highlights the challenges and considerations specific to this population. While topicals are essential for treating plaque psoriasis, especially when combined with systemic therapy, scalp psoriasis presents unique difficulties, particularly for patients with afro-textured hair.

Formulation plays a crucial role, with patients often preferring oils, foams, or lotions over creams or ointments for the scalp. Hair care practices and styling preferences further complicate treatment adherence, requiring dermatologists to consider individual patient habits.

Concerns about hypopigmentation and other pigmentary alterations limit the use of traditional topical corticosteroids in patients with skin of color. Dermatologists may have a lower threshold for initiating systemic therapy due to these concerns.

Combination therapy, such as combining non-steroidal products with steroids, can enhance efficacy while minimizing irritation. Newer non-steroidal topicals offer promising options, with once-daily application and minimal risk of pigmentary sequelae.

Clinical experience suggests that these newer topicals can normalize skin color without exacerbating pigmentary changes, offering a valuable alternative for patients concerned about adverse events from traditional treatments.

EP: 1.Presentation of and Challenges in Treatment of Psoriasis in Patients With Skin of Color

EP: 2.Social and Cultural Stigma of Psoriasis in Patients With Skin of Color

EP: 3.Communicating With Patients With Psoriasis With Skin of Color

EP: 4.Post-Inflammatory Dyspigmentation in Patients With Skin of Color

Now Viewing

EP: 5.Topical Treatments for Psoriasis for Patients With Skin of Color

EP: 6.Traditional Systemic Therapy for Psoriasis for Patients With Skin of Color

EP: 7.Guselkumab in Patients With Skin of Color: VISIBLE Trial Design

EP: 8.Results of VISIBLE Trial in Patients With Skin of Color

EP: 9.Early Use of Systemic Treatments in Patients With Skin of Color

EP: 10.Data With Biologics in Patients With Skin of Color

EP: 11.Advice for Dermatologists in Treating Psoriasis in Patients With Skin of Color

Overall, the conversation underscores the importance of tailoring treatment to the specific needs and characteristics of patients with skin of color, ensuring both efficacy and safety in managing psoriasis.

Video synopsis is AI-generated and reviewed by HCPLive editorial staff.